Introduction
During the early stages of the COVID-19 pandemic, clinical laboratories faced significant safety challenges. While SARS-CoV-2 is primarily a respiratory pathogen, its presence in blood posed a risk to technicians, particularly during procedures like centrifugation that generate infectious aerosols. In resource-limited settings where advanced biosafety equipment may be unavailable, finding a simple method to neutralize the virus before testing was critical. This study investigates whether pasteurizing blood samples at 56°C for 30 minutes—a protocol known to inactivate SARS-CoV-2—interferes with essential transfusion compatibility tests.
Methodology
Researchers at Xiangya Hospital, Central South University, employed a split-sample experimental design. Clinical blood samples (covering types A, B, O, and AB with various Rh factors) were divided into two groups: an untreated control group and an experimental group pasteurized at 56°C for 30 minutes. The team then performed a battery of standard tests, including ABO and Rh typing, irregular antibody screening, and cross-matching, to determine if heat treatment compromised diagnostic accuracy.
Results: Antigen Stability and Rh Typing
The study found that ABO antigens on red blood cells are remarkably resilient to heat. Agglutination intensity for ABO typing remained at a maximum "4+" score in both heated and unheated samples. However, the Rh D-antigen showed a slight decrease in reactivity following pasteurization.
As shown in Figure 4, while the ABO results remained consistent, the Rh D-antigen (column D) often saw a reduction in agglutination intensity from 4+ to 2+ or 3+. Crucially, these results remained clearly positive, ensuring that no false negatives occurred despite the slight "heat tax" on reactivity.
Results: Antibody Screening and Cross-matching
Similar to the Rh D-antigen, certain irregular antibodies exhibited reduced reactivity after heat treatment. High-intensity (4+) reactions were often reduced to 3+ intensity, while negative and low-intensity samples remained stable.
Figure 3 illustrates that while the intensity of the reaction bands in the gel microcolumn cards may shift slightly for higher-grade antibodies, the diagnostic outcome remains interpretable. Primary cross-matching showed no observable negative effects from the pasteurization process.
Discussion: Technical Considerations and Clinical Outcomes
A key technical insight from the study involves the "fragmentation trap." Heat treatment causes some red blood cells to rupture (hemolysis), creating fragments that can become trapped in gel microcolumn cards, potentially leading to false positives. Consequently, the authors recommend using the classic test-tube method for typing heat-treated blood, while the anti-human-globulin card method remains suitable for antibody screening.
Clinical validation was performed on patients with suspected COVID-19 who required red blood cell transfusions. Transfusions based on these heat-treated compatibility tests were successful; patients showed improved clinical symptoms and expected rises in 24-hour hemoglobin levels without any adverse hemolytic reactions.
Conclusion
Pasteurizing blood samples at 56°C for 30 minutes is a viable, low-cost safety measure for laboratories in high-risk or low-resource environments. While it slightly reduces the intensity of Rh and antibody reactions, it does not compromise the fundamental accuracy of transfusion compatibility testing, providing a pragmatic solution to protect laboratory personnel from viral exposure.
Summary updated